Rx (Prescription Medicine)
USD $ 607.00
Hermab 440mg 注射液是一种专门用于治疗特定医学病症的药物。其活性成分 Etanercept 是一种生物制剂，属于疾病修饰抗风湿药（DMARD），通过抑制并中和一种称为肿瘤坏死因子-α（TNF-α）的蛋白质起作用。TNF-α 是多种自身免疫性疾病中导致炎症和组织损伤的关键因子。通过阻断 TNF-α，Hermab 440mg 注射液能够降低炎症、缓解疼痛，并减缓关节损伤及其他相关症状的进展。
Hermab 440mg 注射液适用于治疗成人的中至重度类风湿性关节炎、皮肤性关节炎、强直性脊柱炎以及斑块型银屑病。它也用于 4 岁及以上儿童的多关节性幼年特发性关节炎的治疗。
典型的用药剂量和给药方案将由您的医疗机构根据您的具体病情和治疗反应确定。务必严格遵医嘱。常见的不良反应可能包括注射部位反应（红肿、瘙痒、疼痛）、上呼吸道感染、头痛以及恶心。虽然罕见，但可能出现严重不良反应，包括感染风险增加、过敏反应以及神经系统事件。如出现新发或加重的症状，请立即向医生报告。
Hermab 440mg 注射液应储存在室温、避光防潮的环境中。不可冷藏或冷冻。请放在儿童不易触及的地方。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Trastuzumab 440 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
